Avatrombopag, CAS [[570406-98-3]]

Produktübersicht

• Artikelname: Avatrombopag, CAS [[570406-98-3]]
• Artikelnummer: MCE-HY-13463
• Hersteller Artikelnummer: HY-13463
• Alternativnummer: MCE-HY-13463-5MG,MCE-HY-13463-1G,MCE-HY-13463-10MMX1ML,MCE-HY-13463-25MG,MCE-HY-13463-250MG,MCE-HY-13463-10MG,MCE-HY-13463-500MG,MCE-HY-13463-50MG,MCE-HY-13463-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: AKR-501, E5501, YM477

Produktbeschreibung

Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag mimics the biological activities of TPO. Avatrombopag increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A[1][2][3].

Produkteigenschaften

• Molekulargewicht: 649.65
• Reinheit: 99.83
• CAS Nummer: [570406-98-3]
• Formel: C29H34Cl2N6O3S2
• Target-Kategorie: Thrombopoietin Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound